Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to -$6000.0.

  • Cross Country Healthcare's Cash from Financing Activities rose 9994.97% to -$6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.6 million, marking a year-over-year increase of 7852.32%. This contributed to the annual value of -$46.8 million for FY2024, which is 7882.44% up from last year.
  • Cross Country Healthcare's Cash from Financing Activities amounted to -$6000.0 in Q3 2025, which was up 9994.97% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, Cross Country Healthcare's Cash from Financing Activities peaked at $78.2 million during Q4 2021, and registered a low of -$114.9 million during Q2 2023.
  • For the 5-year period, Cross Country Healthcare's Cash from Financing Activities averaged around -$12.8 million, with its median value being -$6.4 million (2023).
  • Per our database at Business Quant, Cross Country Healthcare's Cash from Financing Activities surged by 286706.76% in 2021 and then plummeted by 75655.98% in 2022.
  • Over the past 5 years, Cross Country Healthcare's Cash from Financing Activities (Quarter) stood at $78.2 million in 2021, then crashed by 92.23% to $6.1 million in 2022, then plummeted by 205.61% to -$6.4 million in 2023, then skyrocketed by 36.46% to -$4.1 million in 2024, then soared by 99.85% to -$6000.0 in 2025.
  • Its Cash from Financing Activities stands at -$6000.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$4.7 million for Q1 2025.